Serious adverse events: No serious adverse events have been reported in the published research on either BPC-157 or TB-500 at therapeutic doses
Epithalon Peptide Therapy: Enhancing Mitochondrial Function to Improve Healthspan & Longevity Epithalon Peptide Therapy: Enhancing Mitochondrial Function to Improve Healthspan & Longevity Epithalon Peptide Therapy: Enhancing Mitochondrial Function to Improve Healthspan & Longevity Aging, unless you have superpowers, is a complex process driven by mitochondrial dysfunction, telomere shortening, chronic inflammation, genomic instability, and the loss of autonomic nervous system homeostasis, among other factors
GLP-1 slows the stomach and dampens appetite
Campbell JD, McDonough JE, Zeskind JE, Hackett TL, Pechkovsky DV, Brandsma CA, Suzuki M, Gosselink JV, Liu G, Alekseyev YO, Xiao J, Zhang X, Hayashi S, Cooper JD, Timens W, Postma DS, Knight DA, Lenburg ME, Hogg JC, Spira A
doi: 10.1016/j.apsb.2024.10.004 40